pravastatin has been researched along with cardiovascular agents in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruschke, AV; Crijns, HJ; Jukema, JW; Lie, KI; van Boven, AJ; Zwinderman, AH | 1 |
| Azie, NE; Becker, PA; Brater, DC; Hall, SD; Jones, DR | 1 |
| Wheeler, DC | 1 |
| Armstrong, PW; Borer, J; Lorell, BH; Nissen, S | 1 |
| Kumar, V; Shah, RP; Singh, S | 1 |
1 review(s) available for pravastatin and cardiovascular agents
| Article | Year |
|---|---|
Are there potential non-lipid-lowering uses of statins?
Topics: Animals; Antineoplastic Agents; Cardiovascular Agents; Enzyme Inhibitors; Graft Occlusion, Vascular; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Diseases; Naphthalenes; Pravastatin | 1998 |
2 trial(s) available for pravastatin and cardiovascular agents
| Article | Year |
|---|---|
Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group.
Topics: Angina Pectoris; Anticholesteremic Agents; Cardiovascular Agents; Cholesterol; Drug Therapy, Combination; Electrocardiography, Ambulatory; Humans; Male; Middle Aged; Myocardial Ischemia; Pravastatin; Prospective Studies | 1996 |
The interaction of diltiazem with lovastatin and pravastatin.
Topics: Administration, Oral; Adult; Anticholesteremic Agents; Area Under Curve; Cardiovascular Agents; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Drug Administration Schedule; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Mixed Function Oxygenases; Pravastatin; Reference Values | 1998 |
2 other study(ies) available for pravastatin and cardiovascular agents
| Article | Year |
|---|---|
Pravastatin and Aspirin.
Topics: Advisory Committees; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Drug Packaging; Drug Therapy, Combination; Humans; Hypertension; Pravastatin | 2002 |
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products.
Topics: Aspirin; Atenolol; Atorvastatin; Cardiovascular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Drug Stability; Heptanoic Acids; Hydrochlorothiazide; Lisinopril; Pravastatin; Pyrroles; Simvastatin; Spectrometry, Mass, Electrospray Ionization | 2008 |